Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Join | Sign in
Home>News

  News Archive

Protein Responsible for Blood Vessel Growth in Tumours Discovered
Wednesday, July 01, 2015
Scientists have discovered a new protein which triggers the growth of blood vessels in breast cancer tumours which have spread to the brain, a common location which breast cancer can spread to.

Personalized Screening for Ovarian Cancer
Tuesday, June 30, 2015
With 60% of women diagnosed with ovarian cancer dying within five years of diagnosis there has been considerable efforts to try to detect the disease at an earlier stage.

Potential New Class of Cancer Drugs
Tuesday, June 30, 2015
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.

Major Step for Implantable Drug-Delivery Device
Tuesday, June 30, 2015
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.

Allscripts Takes $200m Equity Position in Nanthealth
Tuesday, June 30, 2015
The companies have announced they have taken a significant step forward in their strategic partnership through two cross-investments and a strengthening of their commercial agreement.

Delivering Drugs to the Right Place
Monday, June 29, 2015
Thomas Weimbs has developed a targeted drug delivery method that could potentially slow the progression of polycystic kidney disease.

Oncurious NV Appoints Prof Dr Peter Carmeliet
Saturday, June 27, 2015
Company appoints Prof Carmeliet as its Chief Scientific Strategy Advisor.

Invenra and Oxford BioTherapeutics Enter Collaboration
Friday, June 26, 2015
Collaboration to discover novel therapeutic antibodies targeting cancer.

4SC's Partner Yakult Honsha Starts Clinical Phase I Study in Pancreatic Tract Cancer Patients
Friday, June 26, 2015
Safety, tolerability and efficacy of resminostat in combination with S-1 chemotherapy will be investigated in various dosing schemes in order to determine dose regimen for potential subsequent Phase II trials in advanced pancreatic and/or biliary tract cancer.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 3488
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters